Contributor: Vidya Murthy, WEMBA’42
To learn more about Vidya, click here.

Healthcare cybersecurity has been a challenge for years, if not decades, but has recently become critical to ensure the safe delivery of clinical care. With nearly every device being connected and/or running software these days, the landscape for potential vulnerability is larger than it’s ever been. While recent technology advancements ranging from machine learning to ChatGPT show promise for revolutionizing clinical care delivery, they also enable attackers to rapidly develop new mechanisms for exploiting cybersecurity vulnerabilities.
Almost exactly a year ago, President Biden issued an executive order mandating the recalibration of critical infrastructure cyber defenses to growing maturity of adversaries. This came on the heels of the Senate introducing the Healthcare Cybersecurity Act of 2022 and the Protecting and Transforming Cyber Health Care (PATCH) Act, which collectively expand regulations for medical device manufacturers to ensure mitigations are sufficiently in place through the existing Food and Drug Administration (FDA) approval process.
It is therefore very exciting to see the FDA will begin to reject submissions that don’t detail cybersecurity measures, starting October 1, 2023. While cybersecurity guidance has existed since 2014, the Refuse to Accept (RTA) gives medical device manufacturers (MDMs) 6 months to prepare and implement security measures that will meet the FDA’s expectations. In particular, the guidance requires MDMs to submit a plan to monitor, identify, and address post-market cybersecurity risks, including vulnerability disclosure and related procedures.
What does this mean for you?
If you're a company building a medical device running software, it is now a requirement that you build it to be secure by design, develop strategies to monitor and maintain the security of that device post-market and for the life of the device, generate and maintain a software bill of materials, and generate the requisite documentation proving you've done so as part of your FDA regulatory submission.
If you consume devices - whether as a patient or provider - this means the security burden on you is potentially changing. While cybersecurity may not have been a top line concern for most patients, diabetes care has long considered cybersecurity in care delivery. Providers of healthcare, whether in a clinical setting or otherwise, can also start to recalibrate their security posture with a better baseline ‘guarantee’ for devices approved by the FDA.
While the policy does not affect products already on the market, unless a manufacturer is making a change to the device that necessitates a premarket review, it is certainly an inflection point in the story of cybersecurity considerations for medical devices. The rapid development of regulatory expectations, and continuous improvement combined with community engagement, demonstrate the regulator’s perspective that security is patient safety.
Furthermore, given the FDA’s role in the International Medical Device Regulator Forum (IMDRF), it would be reasonable to expect the international requirements to align with the FDA’s position.
Consider Cybersecurity When Innovating
We often dream of healthcare innovation as changing a clinical intervention or enhancing a patient experience. But increasingly, this includes connecting devices with a desire to ‘do something’ with the data gathered. Increased connectivity ushers in new possibilities for clinical care, while also introducing a mandate for transparency throughout the value chain.
Healthcare must find its own standard for secure connectivity. Many of the startup idioms such as pushing out a minimum viable product, catching a hot trend, moving fast, and breaking things do not work in healthcare.
Developing a more secure health system isn’t just good for the short term but will support the technology community for the next decade. To earn the title of responsible innovators, a concerted effort to address security must be made.
Contact Vidya at: [email protected]